Back to search

Article

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference

2025-08-13

Abstract excerpt

Enhancing myeloid effector cell recruitment may improve immunotherapy by monoclonal antibodies – including that against acute lymphoblastic leukemia (ALL). To assess expression of target antigens in B-ALL, we compared mRNA profiling of 559 patient leukemia samples across 18 molecular subtypes with that of representative cell lines. The latter served as target cells to compare human IgG1 or IgA2 variants against CD...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
12394a33-1f5e-592b-8660-59c82802df50
DOI
10.1101/2025.08.13.669665
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interferenceDOI 10.1101/2025.08.13.669665
Select a neighboring publication to make it the new centre.